Recently, Yizhan Capital completed an exclusive investment of over RMB 50 million in Shanghai Boku Biotechnology Co., Ltd. ("Boku Bio" for short)

Boku Biotechnology is founded on the belief that high performance products and environmental responsibility can go hand in hand. Specializing in fermentation-derived natural ingredients, we are committed to replacing synthetic chemicals with sustainable alternatives for personal and home care, cosmetics, and industrial applications.

Core Team

Jie Zhao

·       PhD from East China University of Science and Technology

·       Formerly worked as a senior R&D manager for listed company and multinational company

·       20 years of experience in microbial fermentation and industrial scale-up

Pinwei Huang

·       PhD from the University of Rochester, postdoctoral fellow at MIT

·       More than 20 years of experience in genetic engineering and protein engineering research

Ronnie Yuan

·       Nationally-recognized high-end introduced talent

·       PhD from Pennsylvania State University

·       Internationally renowned expert in food and cosmetics

Jianfeng Zhang

·       Master degree of East China University of Science and Technology

·       Worked for Shanghai Jahwa, Unilever, Inoherb, Frog Prince and other well-known companies

·       27 years of industry experience

Bio-based surfactants are the company's current key industrialization area. Boku Bio uses naturally derived microbial strains to produce biosurfactants from renewable raw materials 

through a fermentation process, providing 100% bio-based surfactants for personal care, make-up, detergent industry to replace traditional chemical surfactants.

Boku Bio has built two R&D centers in Fengxian District, Shanghai and Tongxiang City, Zhejiang Province, and the cosmetic-grade biosurfactant manufacturing line has been put into 

production. At present, Boku Bio has successfully achieved the industrial scale-up and market supply of cosmetic-grade biosurfactants such as lactonic sophorolipids, acidic sophorolipids,

 rhamnolipids and sodium surfactin, and also supplies fermented oil products to leading companies in the personal care industry.

Yizhan Capital is committed to the core strategy of “industry as the foundation, capital as the wings,” dedicated to deeply integrating real industries with equity investment to build

 a unique “industry + capital” dual-drive model. Through industry cultivation and capital empowerment, it promotes scientific and technological innovation and industrial 

modernization, pursuing a path of high-quality development.

The additional investment in Boku Bio is not only an important step for Yizhan Capital to deepen its layout in the physical economy, but also a strategic milestone in its transformation 

and upgrading to a higher level. This investment will accelerate the company's in-depth development in the biotechnology and health industries, promote scientific and technological 

innovation and industrial chain upgrading. It marks Yizhan Capital's new height in the integration of industry and finance under the strategic guidance of “industry as the foundation, 

capital as the wings,” injecting strong momentum into the construction of a sustainable industrial ecosystem.